RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 630.37 Million SEK | -15.8% |
| 2022 | 748.65 Million SEK | 26.62% |
| 2021 | 591.27 Million SEK | -2.79% |
| 2020 | 608.23 Million SEK | -9.11% |
| 2019 | 669.21 Million SEK | 17.16% |
| 2018 | 571.19 Million SEK | 4.15% |
| 2017 | 548.43 Million SEK | 8.69% |
| 2016 | 504.59 Million SEK | 34.95% |
| 2015 | 373.91 Million SEK | 36.67% |
| 2014 | 273.59 Million SEK | 37.89% |
| 2013 | 198.41 Million SEK | 10.81% |
| 2012 | 179.05 Million SEK | 42.49% |
| 2011 | 125.66 Million SEK | 6.82% |
| 2010 | 117.63 Million SEK | 42.29% |
| 2009 | 82.67 Million SEK | 33.28% |
| 2008 | 62.02 Million SEK | -2.84% |
| 2007 | 63.84 Million SEK | -6.29% |
| 2006 | 68.12 Million SEK | -0.88% |
| 2005 | 68.73 Million SEK | 79.74% |
| 2004 | 38.24 Million SEK | 87.53% |
| 2003 | 20.39 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 295.12 Million SEK | 83.31% |
| 2024 Q1 | 160.99 Million SEK | -17.24% |
| 2023 FY | 630.37 Million SEK | -15.8% |
| 2023 Q3 | 222.04 Million SEK | 2.12% |
| 2023 Q2 | 217.44 Million SEK | 5.43% |
| 2023 Q1 | 206.25 Million SEK | -8.82% |
| 2023 Q4 | 194.52 Million SEK | -12.39% |
| 2022 Q4 | 226.2 Million SEK | 24.21% |
| 2022 Q2 | 146.84 Million SEK | -24.11% |
| 2022 Q1 | 193.49 Million SEK | 8.93% |
| 2022 FY | 748.65 Million SEK | 26.62% |
| 2022 Q3 | 182.11 Million SEK | 24.02% |
| 2021 Q3 | 129.97 Million SEK | -4.98% |
| 2021 FY | 591.27 Million SEK | -2.79% |
| 2021 Q1 | 146.88 Million SEK | -2.26% |
| 2021 Q4 | 177.64 Million SEK | 36.68% |
| 2021 Q2 | 136.78 Million SEK | -6.88% |
| 2020 Q2 | 152.29 Million SEK | -21.75% |
| 2020 Q1 | 194.62 Million SEK | -6.72% |
| 2020 Q4 | 150.28 Million SEK | 35.34% |
| 2020 FY | 608.23 Million SEK | -9.11% |
| 2020 Q3 | 111.04 Million SEK | -27.09% |
| 2019 Q3 | 136.83 Million SEK | -22.79% |
| 2019 Q2 | 177.23 Million SEK | 20.97% |
| 2019 Q4 | 208.63 Million SEK | 52.47% |
| 2019 FY | 669.21 Million SEK | 17.16% |
| 2019 Q1 | 146.51 Million SEK | -24.91% |
| 2018 FY | 571.19 Million SEK | 4.15% |
| 2018 Q4 | 195.12 Million SEK | 39.57% |
| 2018 Q3 | 139.8 Million SEK | 7.98% |
| 2018 Q2 | 129.47 Million SEK | 21.24% |
| 2018 Q1 | 106.79 Million SEK | -45.29% |
| 2017 FY | 548.43 Million SEK | 8.69% |
| 2017 Q1 | 116.8 Million SEK | -34.24% |
| 2017 Q3 | 105.73 Million SEK | -19.11% |
| 2017 Q2 | 130.7 Million SEK | 11.9% |
| 2017 Q4 | 195.18 Million SEK | 84.6% |
| 2016 Q1 | 90.14 Million SEK | -25.32% |
| 2016 FY | 504.59 Million SEK | 34.95% |
| 2016 Q2 | 113.32 Million SEK | 25.71% |
| 2016 Q3 | 123.49 Million SEK | 8.97% |
| 2016 Q4 | 177.63 Million SEK | 43.84% |
| 2015 FY | 373.91 Million SEK | 36.67% |
| 2015 Q3 | 94.83 Million SEK | 26.16% |
| 2015 Q4 | 120.71 Million SEK | 27.29% |
| 2015 Q2 | 75.16 Million SEK | -9.65% |
| 2015 Q1 | 83.19 Million SEK | -18.82% |
| 2014 Q2 | 50.4 Million SEK | -2.29% |
| 2014 FY | 273.59 Million SEK | 37.89% |
| 2014 Q4 | 102.48 Million SEK | 48.32% |
| 2014 Q3 | 69.1 Million SEK | 37.08% |
| 2014 Q1 | 51.59 Million SEK | -40.66% |
| 2013 Q4 | 86.94 Million SEK | 128.17% |
| 2013 FY | 198.41 Million SEK | 10.81% |
| 2013 Q3 | 38.1 Million SEK | 47.98% |
| 2013 Q2 | 25.75 Million SEK | -45.91% |
| 2013 Q1 | 47.6 Million SEK | -35.85% |
| 2012 Q1 | 38.41 Million SEK | -15.97% |
| 2012 Q3 | 40.09 Million SEK | 52.18% |
| 2012 Q2 | 26.34 Million SEK | -31.42% |
| 2012 FY | 179.05 Million SEK | 42.49% |
| 2012 Q4 | 74.21 Million SEK | 85.11% |
| 2011 Q2 | 24.46 Million SEK | 7.51% |
| 2011 Q3 | 32.72 Million SEK | 33.75% |
| 2011 Q4 | 45.71 Million SEK | 39.69% |
| 2011 FY | 125.66 Million SEK | 6.82% |
| 2011 Q1 | 22.75 Million SEK | -34.52% |
| 2010 Q4 | 34.75 Million SEK | 57.96% |
| 2010 FY | 117.63 Million SEK | 42.29% |
| 2010 Q3 | 22 Million SEK | -32.95% |
| 2010 Q2 | 32.81 Million SEK | 16.96% |
| 2010 Q1 | 28.05 Million SEK | -22.53% |
| 2009 Q1 | 16.73 Million SEK | 0.0% |
| 2009 Q3 | 12.26 Million SEK | -29.78% |
| 2009 FY | 82.67 Million SEK | 33.28% |
| 2009 Q4 | 36.21 Million SEK | 195.39% |
| 2009 Q2 | 17.46 Million SEK | 4.33% |
| 2008 FY | 62.02 Million SEK | -2.84% |
| 2007 FY | 63.84 Million SEK | -6.29% |
| 2006 FY | 68.12 Million SEK | -0.88% |
| 2005 FY | 68.73 Million SEK | 79.74% |
| 2004 FY | 38.24 Million SEK | 87.53% |
| 2003 FY | 20.39 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aino Health AB (publ) | 3.79 Million SEK | -16497.63% |
| Bonzun AB (publ) | -25.25 Million SEK | 2596.054% |
| Kontigo Care AB (publ) | 2.74 Million SEK | -22856.227% |
| Medhelp Care Aktiebolag (publ) | 90.38 Million SEK | -597.421% |
| Surgical Science Sweden AB (publ) | 558.88 Million SEK | -12.792% |